Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity

Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
Drug Metabolism and Disposition October 2000, 28 (10) 1222-1230;
Stephanie R. Faucette
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy L. Hawke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward L. Lecluyse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacy S. Shord
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bingfang Yan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald M. Laethem
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celeste M. Lindley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 28 no. 10 1222-1230
PubMed 
10997944

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 30, 2000
  • Accepted July 6, 2000
  • Published online October 1, 2000.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Stephanie R. Faucette1,
  2. Roy L. Hawke1,
  3. Edward L. Lecluyse2,
  4. Stacy S. Shord1,
  5. Bingfang Yan3,
  6. Ronald M. Laethem4 and
  7. Celeste M. Lindley1
  1. Divisions of 1Pharmacotherapy (S.R.F., R.L.H., S.S.S, C.M.L.) and 2Drug Delivery and Disposition (E.L.L.), School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3Department of Biomedical Sciences (B.Y.), University of Rhode Island, Kingston, Rhode Island; and 4Department of Bioanalysis and Drug Metabolism (R.M.L.), Glaxo Wellcome, Inc., Research Triangle Park, North Carolina
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to September 2023

    AbstractFullPdf
    Aug 201764118
    Sep 2017633610
    Oct 2017613116
    Nov 201728111
    Dec 20170369
    Jan 201874116
    Feb 201872916
    Mar 201854212
    Apr 20186174
    May 201893210
    Jun 20181317
    Jul 20181305
    Aug 20184217
    Sep 201852910
    Oct 201835513
    Nov 20182729
    Dec 201873226
    Jan 201972115
    Feb 20195731
    Mar 20192262
    Apr 201930133
    May 20191877
    Jun 20191477
    Jul 20192165
    Aug 201920125
    Oct 20193013
    Nov 20193432
    Dec 201922193
    Jan 202020111
    Feb 20203771
    Mar 20202271
    May 20201294
    Jun 20203666
    Jul 20201420
    Aug 20201223
    Sep 202028120
    Oct 202050195
    Nov 202039125
    Dec 202025160
    Jan 202117592
    Feb 202111542
    Mar 20211871
    Apr 20212781
    May 202130200
    Jun 202123401
    Jul 20212390
    Aug 202120500
    Sep 202118193
    Oct 202119112
    Nov 202151112
    Dec 202136126
    Jan 20221090
    Feb 20221765
    Mar 20223541
    Apr 202228135
    May 20222880
    Jun 20224063
    Jul 20224620
    Aug 20221993
    Sep 202237111
    Oct 202234485
    Nov 20223832
    Dec 20222540
    Jan 202347100
    Feb 20232880
    Mar 202358143
    Apr 202357162
    May 202349411
    Jun 20233310
    Jul 20233340
    Aug 202339360
    Sep 20232381

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition: 28 (10)
    Drug Metabolism and Disposition
    Vol. 28, Issue 10
    1 Oct 2000
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity

    Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
    Drug Metabolism and Disposition October 1, 2000, 28 (10) 1222-1230;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleArticle

    Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity

    Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
    Drug Metabolism and Disposition October 1, 2000, 28 (10) 1222-1230;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Ontogeny of CPPGL
    • Expression of AKR and SDR Isoforms in the Human Intestine
    • Interaction of Human OATP1B1 with PDZK1
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics